91 related articles for article (PubMed ID: 25948312)
1. [Influence of systemic inflammatory response syndrome on the pharmacokinetics of vancomycin].
Irikuchi J; Imai T; Yoshida Y; Orii T
Yakugaku Zasshi; 2015; 135(5):745-51. PubMed ID: 25948312
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of Pharmacotherapy on Emergency and Intensive Care Medicine: The Influence of Intensity and Duration of Invasion].
Imai T
Yakugaku Zasshi; 2017; 137(12):1427-1430. PubMed ID: 29199252
[TBL] [Abstract][Full Text] [Related]
3. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
[TBL] [Abstract][Full Text] [Related]
4. Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis.
Shimamoto Y; Fukuda T; Tanaka K; Komori K; Sadamitsu D
Intensive Care Med; 2013 Jul; 39(7):1247-52. PubMed ID: 23604132
[TBL] [Abstract][Full Text] [Related]
5. [Correlation of pharmacokinetic parameters with serum vancomycin concentration in elderly patients with malignancies].
Sadoh S; Tsuji Y; Tsukamoto K
Yakugaku Zasshi; 2010 Jan; 130(1):69-73. PubMed ID: 20046068
[TBL] [Abstract][Full Text] [Related]
6. Influence of cerebral fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients.
Ichie T; Urano K; Suzuki D; Okada T; Kobayashi N; Hayashi H; Sugiura Y; Yamamura K; Sugiyama T
Pharmazie; 2015 Jun; 70(6):404-9. PubMed ID: 26189303
[TBL] [Abstract][Full Text] [Related]
7. [Bayesian forecasting of plasma vancomycin concentration using time-dependent pharmacokinetics].
Nakamura T; Wakaki N; Kimura Y; Goto N; Masada M
Yakugaku Zasshi; 1996 Nov; 116(11):876-83. PubMed ID: 8981831
[TBL] [Abstract][Full Text] [Related]
8. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
[TBL] [Abstract][Full Text] [Related]
9. Change of teicoplanin loading dose requirement for incremental increases of systemic inflammatory response syndrome score in the setting of sepsis.
Nakano T; Nakamura Y; Takata T; Irie K; Sano K; Imakyure O; Mishima K; Futagami K
Int J Clin Pharm; 2016 Aug; 38(4):908-14. PubMed ID: 27125378
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of vancomycin in adult Chinese patients with post-craniotomy meningitis and its application in individualised dosage regimens.
Lin WW; Wu W; Jiao Z; Lin RF; Jiang CZ; Huang PF; Liu YW; Wang CL
Eur J Clin Pharmacol; 2016 Jan; 72(1):29-37. PubMed ID: 26423622
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
[TBL] [Abstract][Full Text] [Related]
12. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
[TBL] [Abstract][Full Text] [Related]
13. Bayesian estimation of pharmacokinetic parameters of vancomycin in patients with decreasing renal function.
Yamamoto T; Terakawa H; Hisaka A; Suzuki H
J Pharm Sci; 2012 Aug; 101(8):2968-75. PubMed ID: 22570265
[TBL] [Abstract][Full Text] [Related]
14. Unexpected serum level of vancomycin after oral administration in a patient with severe colitis and renal insufficiency.
Yamazaki S; Nakamura H; Yamagata S; Miura G; Hattori N; Shinozaki K; Sadahiro T; Toyoda A; Nakasa H; Ariyoshi N; Oda S; Harigaya K; Kitada M
Int J Clin Pharmacol Ther; 2009 Nov; 47(11):701-6. PubMed ID: 19840535
[TBL] [Abstract][Full Text] [Related]
15. An extremely high bioavailability of orally administered vancomycin in a patient with severe colitis and renal insufficiency.
Yamazaki S; Suzuki T; Suzuki T; Takatsuka H; Ishikawa M; Hattori N; Fujishiro T; Miyauchi H; Oami T; Ariyoshi N; Oda S; Matsubara H; Ishii I
J Infect Chemother; 2017 Dec; 23(12):848-851. PubMed ID: 28923303
[TBL] [Abstract][Full Text] [Related]
16. [Validating the Effectiveness of Switching the Vancomycin TDM Analysis Software Based on the Predictive Accuracy].
Imai S; Yamada T; Ishiguro N; Miyamoto T; Kagami K; Tomiyama N; Niinuma Y; Nagasaki D; Suzuki K; Yamagami A; Kasashi K; Kobayashi M; Iseki K
Yakugaku Zasshi; 2017; 137(9):1185-1192. PubMed ID: 28867705
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin pharmacokinetics in critically ill patients receiving continuous haemodiafiltration with a polyethyleneimine-coated polyacrylonitrile membrane.
Tsuruyama M; Yamashina T; Tsuruta M; Tsukada H; Fujimoto A; Nagano M; Kawamata Y; Takashima S; Hiraki Y
J Clin Pharm Ther; 2020 Oct; 45(5):1143-1148. PubMed ID: 32497268
[TBL] [Abstract][Full Text] [Related]
18. Interaction between levofloxacin and vancomycin in rats--study of serum and organ levels.
Mori H; Nakajima T; Nakayama A; Yamori M; Izushi F; Gomita Y
Chemotherapy; 1998; 44(3):181-9. PubMed ID: 9612608
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of serum cholinesterase for the prognosis of aged patients with systemic inflammatory response syndrome.
Jin QH; He XJ; Li TL; Chen HH
Chin Med J (Engl); 2011 Sep; 124(17):2692-5. PubMed ID: 22040426
[TBL] [Abstract][Full Text] [Related]
20. Contribution of pharmacists with expertise in infectious diseases to appropriate individualized vancomycin dosing.
Nakashima T; Koido K; Baba H; Otsuka R; Okinaka K; Sano T; Nishigaki R; Hashimoto H; Otsuka T; Esaki M; Terakado H
Pharmazie; 2018 Jul; 73(7):422-424. PubMed ID: 30001779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
